JP2012533322A5 - - Google Patents

Download PDF

Info

Publication number
JP2012533322A5
JP2012533322A5 JP2012521710A JP2012521710A JP2012533322A5 JP 2012533322 A5 JP2012533322 A5 JP 2012533322A5 JP 2012521710 A JP2012521710 A JP 2012521710A JP 2012521710 A JP2012521710 A JP 2012521710A JP 2012533322 A5 JP2012533322 A5 JP 2012533322A5
Authority
JP
Japan
Prior art keywords
expression
ibd
expression level
determining
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012521710A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012533322A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/042487 external-priority patent/WO2011011339A1/en
Publication of JP2012533322A publication Critical patent/JP2012533322A/ja
Publication of JP2012533322A5 publication Critical patent/JP2012533322A5/ja
Pending legal-status Critical Current

Links

JP2012521710A 2009-07-20 2010-07-19 クローン病のための遺伝子発現マーカー Pending JP2012533322A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22704909P 2009-07-20 2009-07-20
US61/227,049 2009-07-20
US30208410P 2010-02-05 2010-02-05
US61/302,084 2010-02-05
PCT/US2010/042487 WO2011011339A1 (en) 2009-07-20 2010-07-19 Gene expression markers for crohn's disease

Publications (2)

Publication Number Publication Date
JP2012533322A JP2012533322A (ja) 2012-12-27
JP2012533322A5 true JP2012533322A5 (https=) 2013-09-05

Family

ID=42732741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012521710A Pending JP2012533322A (ja) 2009-07-20 2010-07-19 クローン病のための遺伝子発現マーカー

Country Status (8)

Country Link
US (2) US20110033486A1 (https=)
EP (3) EP2584049A3 (https=)
JP (1) JP2012533322A (https=)
CN (1) CN102639710A (https=)
AU (1) AU2010276392A1 (https=)
CA (1) CA2768711A1 (https=)
SG (1) SG177699A1 (https=)
WO (1) WO2011011339A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012135142A1 (en) 2011-03-25 2012-10-04 Cedars-Sinai Medical Center Methods of diagnosing ulcerative colitis and crohn's disease
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
WO2015168699A1 (en) * 2014-05-02 2015-11-05 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (mruc) requiring colectomy
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
EP2872646B1 (en) * 2012-07-12 2017-08-30 Institut National de la Sante et de la Recherche Medicale (INSERM) Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes
KR20230109779A (ko) 2013-03-27 2023-07-20 세다르스-신나이 메디칼 센터 Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한섬유증 및 염증의 완화 및 반전
HK1219512A1 (zh) * 2013-05-17 2017-04-07 F. Hoffmann-La Roche Ag 用於诊断和治疗炎性肠病的方法
EP3022295A4 (en) 2013-07-19 2017-03-01 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
WO2015148809A1 (en) * 2014-03-27 2015-10-01 Genentech, Inc. Methods for diagnosing and treating inflammatory bowel disease
KR20240095481A (ko) 2016-03-17 2024-06-25 세다르스-신나이 메디칼 센터 Rnaset2를 통한 염증성 장 질환의 진단 방법
CN107541790B (zh) * 2016-06-24 2021-07-06 上海交通大学 一种糖基化检测的人凝集素/类人凝集素芯片及制备方法
IT201600090052A1 (it) * 2016-09-06 2018-03-06 Univ Degli Studi Padova Peptide per la diagnosi differenziale della Malattia di Crohn
CN106755293B (zh) * 2016-09-23 2020-09-04 宁波大学 一种与肺癌辅助诊断相关的lncRNA标志物及其应用
WO2018067935A1 (en) * 2016-10-06 2018-04-12 The Research Foundation For The State University Of New York Methods and kits for detecting a fusion messenger rna transcript or a polypeptide encoded by the fusion messenger rna transcript
JP7437310B2 (ja) * 2018-03-14 2024-02-22 コーニンクレッカ フィリップス エヌ ヴェ Ｒｎａシーケンシングデータの転写発現レベルを解釈するために局所的なユニークな特徴を使用するシステム及び方法
CN108893488A (zh) * 2018-06-19 2018-11-27 刘志强 一种重组质粒、dna疫苗及其制备方法和应用
AU2020275413A1 (en) 2019-05-14 2021-12-23 Cedars-Sinai Medical Center TL1A patient selection methods, systems, and devices
WO2021057987A1 (zh) * 2019-09-27 2021-04-01 成都中医药大学 检测粪钙卫蛋白含量的试剂在制备畸形精子症筛查试剂盒中的用途
CN116168765B (zh) * 2023-04-25 2023-08-18 山东大学 基于改进strobemer的基因序列生成方法及系统
CN117031004B (zh) * 2023-08-09 2024-10-01 四川省医学科学院·四川省人民医院 一种检测网膜素-1的试剂在制备预测或评估ibs患者生活质量的产品中的应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
ES2096590T3 (es) 1989-06-29 1997-03-16 Medarex Inc Reactivos biespecificos para la terapia del sida.
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
EP0527283B1 (en) 1991-08-12 1997-11-26 Societe Des Produits Nestle S.A. Food composition
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
FI941572A7 (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenete lmä
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
ATE207080T1 (de) 1991-11-25 2001-11-15 Enzon Inc Multivalente antigen-bindende proteine
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
WO1993016177A1 (en) 1992-02-11 1993-08-19 Cell Genesys, Inc. Homogenotization of gene-targeting events
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
CA2140280A1 (en) 1992-08-17 1994-03-03 Avi J. Ashkenazi Bispecific immunoadhesins
US6283761B1 (en) 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
CA2223198A1 (en) 1997-01-14 1998-07-14 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
JP2003531588A (ja) 2000-04-11 2003-10-28 ジェネンテック・インコーポレーテッド 多価抗体とその用途
GB0130955D0 (en) 2001-12-24 2002-02-13 Cancer Res Ventures Expression system
EP1572902B1 (en) 2002-02-01 2014-06-11 Life Technologies Corporation HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
US7378239B2 (en) * 2002-06-25 2008-05-27 Index Diagnostics Ab Method of differentiating between ulcerative colitis and Crohn's disease
AU2004258085B2 (en) 2003-07-10 2010-05-27 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
JP2005102694A (ja) * 2003-09-10 2005-04-21 Japan Science & Technology Agency 末梢血液細胞に示差的に発現されている遺伝子群、およびそれを用いた診断方法とアッセイ方法
WO2006063133A2 (en) * 2004-12-06 2006-06-15 The Johns Hopkins University Biomarker for inflammatory bowel disease
EP2049691A4 (en) * 2006-07-26 2010-06-16 Genizon Biosciences Inc SUSCEPTIBILITY TREASURES FOR MORBUS CROHN
WO2008079406A2 (en) * 2006-12-19 2008-07-03 Genentech, Inc. Gene expression markers for inflammatory bowel disease
EP2160475A4 (en) * 2007-05-22 2011-02-09 Centocor Ortho Biotech Inc MARKERS AND METHOD FOR EVALUATING AND TREATING CROHN'S DISEASE AND ASSOCIATED DISORDERS
WO2008147900A2 (en) * 2007-05-22 2008-12-04 Genentech, Inc. Gene expression markers for inflammatory bowel disease
MX2010005893A (es) * 2007-11-29 2011-03-04 Genentech Inc Star Marcadores de expresion genica para enfermedad inflamatoria de intestino.
DK2223121T3 (da) * 2007-12-20 2012-10-22 Index Diagnostics Ab Publ Fremgangsmåde og kit til anvendelse ved differentiering mellem ibd og ibs og yderligere skelnen mellem ibd-sygdomstyper

Similar Documents

Publication Publication Date Title
JP2012533322A5 (https=)
JP2011509071A5 (https=)
MX2013006669A (es) Conjunto de sondas de oligonucleotido y metodos para perfilado de microbiotica.
JP2012518421A5 (https=)
JP2012500389A5 (https=)
JP2012503985A5 (https=)
JP2014509189A5 (https=)
WO2014186750A2 (en) Variants of tnfsf15 and dcr3 associated with crohn's disease
WO2009116861A3 (en) Diagnostic of pre-symptomatic metabolic syndrome
JP2013178260A5 (https=)
US20160096885A1 (en) Distinct effects of ifn-gamma and il-17 on tl1a modulated inflammation and fibrosis
JP2013505008A5 (https=)
JPWO2019208671A5 (https=)
JP2018504909A5 (https=)
Puente et al. Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma
Murdaca et al. The role of skin and gut microbiome and epigenetic modifications in skin-autoimmune disorders
WO2009125303A3 (en) Method and apparatus for determining a probability of colorectal cancer in a subject
JP2011527575A5 (https=)
Hu et al. Regulation of gene expression of hcp, a core gene of the type VI secretion system in Acinetobacter baumannii causing respiratory tract infection
KR20210144353A (ko) 단일세포 전사체 분석에 기반한 대장암의 예후 예측 방법
Meniaï et al. Putative antigenic proteins identified by comparative and subtractive reverse vaccinology in necrotic enteritis-causing Clostridium perfringens isolated from broiler chickens
JP2012524248A5 (https=)
Shahgoli et al. Expression of FIBCD1 by intestinal epithelial cells alleviates inflammation-driven tumorigenesis in a mouse model of colorectal cancer
JP2009523004A5 (https=)
CN113278612B (zh) tiRNA-Cys-GCA及其在主动脉夹层疾病中应用